(Circulation. 1997;96:4424-4430.)
© 1997 American Heart Association, Inc.
Articles |
Cholesterol Management in Theory and Practice
From Cornell University Medical College, New York, NY.
Correspondence to Antonio M. Gotto, Jr, MD, DPhil, Cornell University Medical College, 1300 York Avenue, F-105, New York, NY 10021. E-mail dean{at}mail.med.cornell.edu
Abstract The preponderance of evidence confirms the importance of aggressive lipid modification in patients at risk for coronary heart disease (CHD). However, data suggest that this information is underimplemented in the clinical setting, even in patients with existing CHD, in whom the greatest benefit of such treatment has been shown. The fact that many practitioners do not pursue a proven treatment strategy in patients who qualify must be redressed through education and reinforcement of existing recommendations. In the present review, the current clinical and mechanistic understanding of the benefit of aggressive lipid management is summarized, with a focus on the clinical implications of recent findings. These include growing public awareness of cholesterol as a modifiable CHD risk factor, recommendations for earlier and more aggressive intervention in patients with existing disease, and discussion of the cost-effectiveness of lipid-regulating therapy. Despite the secular trend of declining CHD morbidity and mortality rates in recent years, CHD remains the leading cause of death in both men and women in the United States. It is imperative to prevent any reduction in public focus on primary and secondary prevention.
Key Words: cholesterol • lipids • atherosclerosis • heart diseases • epidemiology
This article has been cited by other articles:
 |
|
 |
|
  M. R. Smith, S. B. Malkowicz, F. Chu, J. Forrest, P. Sieber, K. G. Barnette, D. Rodriquez, and M. S. Steiner Toremifene Improves Lipid Profiles in Men Receiving Androgen-Deprivation Therapy for Prostate Cancer: Interim Analysis of a Multicenter Phase III Study J. Clin. Oncol., April 10, 2008; 26(11): 1824 - 1829. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. S. Monroe, R. A. Kerensky, E. Rivera, K. M. Smith, and C. J. Pepine Pharmacologic plaque passivation for the reduction of recurrent cardiac events in acute coronary syndromes J. Am. Coll. Cardiol., February 19, 2003; 41(4_Suppl_S): 23S - 30S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. D. Graves and P. M. Miller Behavioral Medicine in the Prevention and Treatment of Cardiovascular Disease Behav Modif, January 1, 2003; 27(1): 3 - 25. [Abstract] [PDF]
|
|
|
|
 |
|
 J. R Mead and D. P Ramji The pivotal role of lipoprotein lipase in atherosclerosis Cardiovasc Res, August 1, 2002; 55(2): 261 - 269. [Full Text] [PDF]
|
|
|
|
 |
|
 C. R. Lacy, D.-C. Suh, J. A. Barone, M. Bueno, D. Moylan, C. Swartz, R. V. Kudipudi, and J. B. Kostis Impact of a Targeted Intervention on Lipid-Lowering Therapy in Patients With Coronary Artery Disease in the Hospital Setting Arch Intern Med, February 25, 2002; 162(4): 468 - 473. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Amarenco Hypercholesterolemia, lipid-lowering agents, and the risk for brain infarction Neurology, September 1, 2001; 57(90002): S35 - 44. [Abstract] [Full Text]
|
|
|
|
|
|
J. Yarzebski, F. Spencer, R. J. Goldberg, D. Lessard, and J. M. Gore Temporal Trends (1986-1997) in Cholesterol Level Assessment and Management Practices in Patients With Acute Myocardial Infarction: A Population-Based Perspective Arch Intern Med, June 25, 2001; 161(12): 1521 - 1528. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Mosca The Role of Hormone Replacement Therapy in the Prevention of Postmenopausal Heart Disease Arch Intern Med, August 14, 2000; 160(15): 2263 - 2272. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. J. Rader and E. Pure Genetic Susceptibility to Atherosclerosis : Insights From Mice Circ. Res., May 26, 2000; 86(10): 1013 - 1015. [Full Text] [PDF]
|
|
|
|
 |
|
 L. Iuliano, A. Mauriello, E. Sbarigia, L. G. Spagnoli, and F. Violi Radiolabeled Native Low-Density Lipoprotein Injected Into Patients With Carotid Stenosis Accumulates in Macrophages of Atherosclerotic Plaque : Effect of Vitamin E Supplementation Circulation, March 21, 2000; 101(11): 1249 - 1254. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. A. McAlister, A. Laupacis, G. A. Wells, D. L. Sackett, and for the Evidence-Based Medicine Working Group Users' Guides to the Medical Literature: XIX. Applying Clinical Trial Results; B. Guidelines for Determining Whether a Drug Is Exerting (More Than) a Class Effect JAMA, October 13, 1999; 282(14): 1371 - 1377. [Full Text] [PDF]
|
|
|
|
|
|
J. Dupuis, J.-C. Tardif, P. Cernacek, and P. Theroux Cholesterol Reduction Rapidly Improves Endothelial Function After Acute Coronary Syndromes : The RECIFE (Reduction of Cholesterol in Ischemia and Function of the Endothelium) Trial Circulation, June 29, 1999; 99(25): 3227 - 3233. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. G. Danias, D. I. Silverman, J. P. Frolkis, P. Suhan, J. Schwartz, and S. J. Zyzanski Physician Noncompliance With the 1993 National Cholesterol Education Program (NCEP-ATPII) Guidelines • Response Circulation, June 29, 1999; 99 (25): 3323 - 3326. [Full Text] [PDF]
|
|
|
|
|
|
L. Mosca, S. M. Grundy, D. Judelson, K. King, M. Limacher, S. Oparil, R. Pasternak, T. A. Pearson, R. F. Redberg, S. C. Smith Jr, et al. Guide to Preventive Cardiology for Women Circulation, May 11, 1999; 99(18): 2480 - 2484. [Full Text] [PDF]
|
|
|
|
|
|
A. Szczeklik, J. Musial, A. Undas, P. Gajewski, P. Gora, J. Swadzba, and M. Jankowski Inhibition of thrombin generation by simvastatin and lack of additive effects of aspirin in patients with marked hypercholesterolemia J. Am. Coll. Cardiol., April 1, 1999; 33(5): 1286 - 1293. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. E. Gutstein and V. Fuster Pathophysiology and clinical significance of atherosclerotic plaque rupture Cardiovasc Res, February 1, 1999; 41(2): 323 - 333. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. P. Frolkis, S. J. Zyzanski, J. M. Schwartz, and P. S. Suhan Physician Noncompliance With the 1993 National Cholesterol Education Program (NCEP-ATPII) Guidelines Circulation, September 1, 1998; 98(9): 851 - 855. [Abstract] [Full Text] [PDF]
|
|